No 10Y consistency score yet for revenue — the window needs more comparable quarters.
Valuation vs own 10Y history: P/S 0.2x · 10Y median 0.7x · 7th percentile · as of Oct 5, 2026
Annualized revenue (TTM) · by quarter, last 28
Quarterly YoY revenue growth vs the 20% line
P/S multiple vs its 10Y median
FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters. Quote observation: 2026-10-06T12:46:01.094Z. Latest historical point 2026-10-05. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
Current FMP quote-based enterprise value / four-quarter operating income plus matched D&A. Quote observation: 2026-10-06T12:46:01.094Z. Latest historical point 2026-09-29. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
FMP quote market capitalization / four-quarter operating cash flow. Quote observation: 2026-10-06T12:46:01.094Z. Latest historical point 2026-10-05. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
FMP quote market capitalization / four-quarter operating cash flow less absolute capital expenditures. Quote observation: 2026-10-06T12:46:01.094Z. Latest historical point 2026-10-05. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
Unrounded diluted TTM EPS / FMP quote price × 100. Quote observation: 2026-10-06T12:46:01.094Z. Latest historical point 2026-01-28.
Four-quarter operating EBITDA / current FMP quote-based enterprise value × 100. Quote observation: 2026-10-06T12:46:01.094Z. Latest historical point 2026-09-29. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
Four-quarter operating cash flow / FMP quote market capitalization × 100. Quote observation: 2026-10-06T12:46:01.094Z. Latest historical point 2026-10-05. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
Four-quarter free cash flow / FMP quote market capitalization × 100. Quote observation: 2026-10-06T12:46:01.094Z. Latest historical point 2026-10-05. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
The latest delayed quote for Concentrix Corporation (CNXC) stock was $25.87 as of Oct 5, 2026, 4:00 PM EDT, up 3.85% from the previous close.
Longer view (total return, dividends reinvested): past 12 months -43.7% · 3-year avg -28.7%/yr · 5-year avg -30.5%/yr
Concentrix Corporation operates globally, specializing in providing technology-enhanced solutions to optimize customer experiences (CX). The company's services encompass a wide array of offerings, including streamlining CX processes, driving technological innovation, automating both front-end and back-end operations, delivering insightful analytics, and facilitating comprehensive business transformations.
Information Technology Services · Newark, CA
Selected amounts supplied by FMP for each displayed period. Reviewed label references appear where available; other labels are unverified, and items may overlap.
2025-11-30 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
2025-11-30 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Next Earnings Date
Jan 12, 2027
98 days away
EPS Estimate
2.92
Revenue Est.
$2.44B
Last Quarter Results
EPS
$2.92
vs Estimate
$2.70
Revenue
| Stock | Market Cap | Close Price | Price Change | TTM Total Return | 5Y CAGR | 10Y CAGR | Compare |
|---|---|---|---|---|---|---|---|
| 1CNXC | $1.58B | $25.87 | +3.85% | -43.66% | -30.54% | N/A | N/A |
| 2EVCM | $1.60B | $9.07 | +1.45% | -17.69% | -12.23% | N/A | vs CNXC |
| 3ALKT | $1.51B | $14.15 | +1.87% | -42.30% | -11.01% | N/A | vs CNXC |
| 4BL | $1.65B | $28.13 | +2.63% | -45.34% | -24.76% | N/A | vs CNXC |
| 5SHAZ | $1.67B | $47.70 | -6.12% | N/A | N/A | N/A | vs CNXC |
| 6AI | $1.69B | $11.09 | +0.73% | -41.97% | -24.04% | N/A | vs CNXC |
0.89
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
$2.45B
vs Estimate
$2.48B
Consensus Rating
Based on 4 analysts
Average Price Target
$33.50
+29.5% upside
Low
$29.00
Current
$25.87
High
$45.00
Quarterly
| Period | Low | Avg | High | # Analysts |
|---|---|---|---|---|
| Quarter ending Aug 2026 | $2.68 | $2.71 | $2.74 | 2 |
| Quarter ending Nov 2026 | $2.89 | $2.92 | $2.96 | 3 |
| Quarter ending Feb 2027 | $2.62 | $2.81 | $2.97 | 3 |
| Quarter ending May 2027 | $2.78 | $2.81 | $2.84 | 1 |
Annual
| Period | Low | Avg | High | # Analysts |
|---|---|---|---|---|
| FY 2026 | $10.99 | $11.07 | $11.12 | 3 |
| FY 2027 | $11.60 | $11.66 | $11.71 | 3 |
Quarterly
| Period | Low | Avg | High | # Analysts |
|---|---|---|---|---|
| Quarter ending Aug 2026 | $2.46B | $2.48B | $2.50B | 2 |
| Quarter ending Nov 2026 | $2.42B | $2.44B | $2.47B | 2 |
| Quarter ending Feb 2027 | $2.40B | $2.43B | $2.47B | 3 |
| Quarter ending May 2027 | $2.41B | $2.43B | $2.45B | 1 |
Annual
| Period | Low |
|---|
Source: FMP Analyst Consensus Estimates. Forward P/E uses the consensus EPS estimate for the fiscal year ending Nov 30, 2026, matching Key Metrics.
| Avg |
|---|
| High |
|---|
| # Analysts |
|---|
| FY 2026 | $9.80B | $9.86B | $9.89B | 3 |
| FY 2027 | $9.77B | $9.82B | $9.86B | 3 |
